{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T14:21:52Z","timestamp":1694787712737},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1007\/bf03401311","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T09:41:07Z","timestamp":1533721267000},"page":"454-460","source":"Crossref","is-referenced-by-count":9,"title":["Familial isolated primary hyperparathyroidism due to HRPT2 mutation"],"prefix":"10.1007","volume":"12","author":[{"given":"Adina","family":"Ghemigian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mircea","family":"Ghemigian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavinia","family":"Vija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoleta","family":"Dumitru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dumitru","family":"Ioachim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,1]]},"reference":[{"key":"BF03401311_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1359\/JBMR.050910","volume":"21","author":"RA Weimers","year":"2006","unstructured":"Weimers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, 2006 Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease. J Bone Miner Res 21: 171\u2013177.","journal-title":"J Bone Miner Res"},{"key":"BF03401311_CR2","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi ML, Gagel RF, Angeli A, et al, 2001 Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86: 5658\u20135671.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401311_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1365-2796.2004.01422.x","volume":"257","author":"JP Bilezikian","year":"2005","unstructured":"Bilezikian JP, Brandi ML, Rubin M, Silverberg SJ, 2005 Primary hyperparathyroidism: new concepts in clinical, densitometric, and biochemical features. J Int Med 257: 6\u201317.","journal-title":"J Int Med"},{"key":"BF03401311_CR4","unstructured":"Gardner DG, Shoback D, 2007. In Greenspan\u2019s Basic and Clinical Endocrinology, Chapter 23, McGraw Hill Medical."},{"key":"BF03401311_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/332085a0","volume":"332","author":"C Larsson","year":"1988","unstructured":"Larsson C, Skogseid B, Oberg K, et al, 1988 Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332: 85\u201387.","journal-title":"Nature"},{"key":"BF03401311_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1126\/science.276.5311.404","volume":"276","author":"SC Chandrasekharappa","year":"1997","unstructured":"Chandrasekharappa SC, Guru SC, Manickam P, et al, 1997 Positional cloning of the gene for multiple endocrine neoplasia-type I. Science 276: 404\u2013407.","journal-title":"Science"},{"key":"BF03401311_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0092-8674(00)80967-8","volume":"96","author":"SK Agarwal","year":"1999","unstructured":"Agarwal SK, Guru SC, Heppner C, et al, 1999 Menin interacts with the AP1 transcription factor JunD and represses JunD-activated transcription. Cell 96: 143\u2013152.","journal-title":"Cell"},{"key":"BF03401311_CR8","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0603877103","volume":"103","author":"NS Pellegata","year":"2006","unstructured":"Pellegata NS, Quintanilla-Martinez L, Siggelkow H, et al, 2006 Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. Proc Nat Acad Sci USA 103: 15558\u201315563.","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF03401311_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","volume":"81","author":"WF Simonds","year":"2002","unstructured":"Simonds WF, James-Newton LA, Agarwal SK, et al, 2002 Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 81: 1\u201326.","journal-title":"Medicine (Baltimore)"},{"key":"BF03401311_CR10","first-page":"944","volume":"56","author":"J Szabo","year":"1995","unstructured":"Szabo J, Heath B, Hill VM, et al, 1995 Hereditary hyperparathyroidism-jaw-tumor syndrome: the endocrine-tumor gene HRPT2 maps to chromosome 1q21\u2013q31. Am J Hum Genet 56: 944\u2013950.","journal-title":"Am J Hum Genet"},{"key":"BF03401311_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","volume":"81","author":"WF Simonds","year":"2002","unstructured":"Simonds WF, James-Newton LA, Agarwal SK, et al, 2002 Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 81: 1\u201326.","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl. 2","key":"BF03401311_CR12","first-page":"N37","volume":"17","author":"SJ Marx","year":"2002","unstructured":"Marx SJ, Simonds SF, Agarwal SK, et al, 2002 Hyperparathyroidism in hereditary syndromes: special expressions and special managements. J Bone Min Res 17(suppl. 2): N37\u201343.","journal-title":"J Bone Min Res"},{"key":"BF03401311_CR13","first-page":"1752","volume":"85","author":"C Larsson","year":"2000","unstructured":"Larsson C, 2000 Dissecting the Genetics of Hyperparathyroidism\u2014New Clues from an Old Friend, J Clin Endocrinol Metab 85: 1752\u20131754.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401311_CR14","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ng1048","volume":"32","author":"JD Carpten","year":"2002","unstructured":"Carpten JD, Robbins CM, Villablanca A, et al, 2002 HRPT2, encoding parafibromin, is mutated in HPT-jaw tumor syndrome. Nat Genet 32: 676\u2013680.","journal-title":"Nat Genet"},{"key":"BF03401311_CR15","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, Valimaki S, Obara T, et al, 2003 Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349: 1722\u20131729.","journal-title":"N Engl J Med"},{"key":"BF03401311_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1210\/jc.2003-030675","volume":"89","author":"WF Simonds","year":"2004","unstructured":"Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ, 2004 Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 89: 96\u2013102.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401311_CR17","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/sj.onc.1209893","volume":"26","author":"KJ Bradley","year":"2007","unstructured":"Bradley KJ, Bowl MR, Williams SE, et al, 2007 Parafibromin is a nuclear protein with a functional monopartite nuclear localization signal. Oncogene 26: 1213\u20131221.","journal-title":"Oncogene"},{"key":"BF03401311_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1158\/1541-7786.MCR-06-0129","volume":"5","author":"L Lin","year":"2007","unstructured":"Lin L, Czapiga M, Nini L, Zhang JH, Simonds WF, 2007 Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism-jaw tumor syndrome enhances its proapoptotic function. Molecular Cancer Research: MCR 5: 183\u2013193.","journal-title":"Molecular Cancer Research: MCR"},{"key":"BF03401311_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/nar\/gkp991","volume":"38","author":"YJ Yang","year":"2010","unstructured":"Yang YJ, Han JW, Youn HD, Cho EJ, 2010 The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression. Nucleic Acids Research 38: 382\u2013390.","journal-title":"Nucleic Acids Research"},{"key":"BF03401311_CR20","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/sj.onc.1208274","volume":"24","author":"GE Woodard","year":"2005","unstructured":"Woodard GE, Lin L, Zhang JH, et al, 2005 Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1\/PRAD1 expression. Oncogene 24: 1272\u20131276.","journal-title":"Oncogene"},{"key":"BF03401311_CR21","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1128\/MCB.25.2.612-620.2005","volume":"25","author":"O Rozenblatt-Rosen","year":"2005","unstructured":"Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, et al, 2005 The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol 25: 612\u2013620.","journal-title":"Mol Cell Biol"},{"key":"BF03401311_CR22","doi-asserted-by":"publisher","first-page":"7499","DOI":"10.1038\/sj.onc.1210582","volume":"26","author":"K Chaudhary","year":"2007","unstructured":"Chaudhary K, Deb S, Moniaux N, Ponnusamy MP, Batra SK, 2007 Human RNA polymerase II-associated factor complex: dysregulation in cancer. Oncogene 26: 7499\u20137507.","journal-title":"Oncogene"},{"key":"BF03401311_CR23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/mc.20591","volume":"49","author":"LJ Farber","year":"2010","unstructured":"Farber LJ, Kort EJ, Wang P, Chen J, Teh BT, 2010 The tumor suppressor parafibromin is required for posttranscriptional processing of histone mRNA. Mol Carcinog 49: 215\u2013223.","journal-title":"Mol Carcinog"},{"key":"BF03401311_CR24","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","volume":"75","author":"MR Pollak","year":"1993","unstructured":"Pollak MR, Brown EM, Chou YH, et al, 1993 Mutations in the human Ca(2+) sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell. 75: 1297\u20131303.","journal-title":"Cell."},{"key":"BF03401311_CR25","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/B978-0-12-373884-4.00074-4","volume-title":"Principles of Bone Biology","author":"GE Fuleihan","year":"2008","unstructured":"Fuleihan GE, Brown EM, Heath HH III 2008 Familial benign hypocalciuric hypercalcemia and neonatal primary hyperparathyroidism. In: Principles of Bone Biology, Bilezikian JP, Raisz LG, Martin TJ, (eds) Academic Press, San Diego; pp, 1327\u20131345."},{"key":"BF03401311_CR26","first-page":"2114","volume":"83","author":"BT Teh","year":"1998","unstructured":"Teh BT, Farnebo F, Twigg S, et al, 1998 Familial isolated hyperparathyroidism maps to the hyperparathyroidismjaw tumor locus in 1q21\u2013q32 in a subset of families. J Clin Endocrinol Metab 83: 2114\u20132120.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401311_CR27","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1002\/gcc.20911","volume":"50","author":"A Casc\u00f3n","year":"2011","unstructured":"Casc\u00f3n A, Huarte-Mendicoa CV, Javier Leandro-Garcia L, et al, 2011 Detection of the first gross CDC73 germline deletion in an HPT-JT syndrome family. Genes Chromosomes Cancer 50: 922\u2013999.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF03401311_CR28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/9780470623992.ch76","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"A Arnold","year":"2008","unstructured":"Arnold A, 2008 Familial hyperparathyroidism. In: Rosen CJ, (ed) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, Washington, DC: American Society for Bone and Mineral Research, pp, 361\u2013367."},{"key":"BF03401311_CR29","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1359\/jbmr.081018","volume":"23","author":"C Marcocci","year":"2008","unstructured":"Marcocci C, Cetani F, Rubin MR, Silverberg SJ, Pinchera A, Bilezikian JP, 2008 Parathyroid Carcinoma. J Bone Miner Res 23: 1869\u20131880.","journal-title":"J Bone Miner Res"},{"key":"BF03401311_CR30","first-page":"165","volume":"85","author":"M Kassem","year":"2000","unstructured":"Kassem M, Kruse TA, Wong F-K, et al, 2000 Familial isolated hyperparathyroidism\u2014a variant of MEN1. J Clin Endocrinol Metab 85: 165\u2013167.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03401311_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1046\/j.1365-2265.2003.01765.x","volume":"58","author":"AA Pannett","year":"2003","unstructured":"Pannett AA, Kennedy AM, Turner JJ, et al, 2003 Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. Clin Endocrinol (Oxf) 58: 639\u2013646.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"BF03401311_CR32","first-page":"3509","volume-title":"Endocrinology","author":"RV Thakker","year":"2006","unstructured":"Thakker RV, 2006 Multiple Endocrine Neoplasia Type 1. In Endocrinology, DeGroot LJ, Jameson JL (eds) Philadelphia, PA: WB Saunders, pp, 3509\u20133531."},{"key":"BF03401311_CR33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/ncpendmet0718","volume":"4","author":"FM Hannan","year":"2008","unstructured":"Hannan FM, Nesbit AM, Christie PT, et al, 2008 Familial Isolated Primary Hyperparathyroidism Caused by Mutations of the MEN1 Gene. Nat Clin Pract Endocrinol Metab 4: 53\u201358.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"BF03401311_CR34","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","volume":"335","author":"SH Pearce","year":"1996","unstructured":"Pearce SH, Williamson C, Kifor O, et al, 1996 A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335: 1115\u20131122.","journal-title":"N Engl J Med"},{"key":"BF03401311_CR35","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/350512a0","volume":"350","author":"T Motokura","year":"1991","unstructured":"Motokura T, Bloom T, Kim HG, et al, 1991 A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature 350: 512\u2013515.","journal-title":"Nature"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03401311\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03401311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03401311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T12:14:10Z","timestamp":1604751250000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03401311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["BF03401311"],"URL":"https:\/\/doi.org\/10.1007\/bf03401311","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}